2026-01-18 - Analysis Report
**English Report**
================

**1. Company Overview**
-------------------

Estee Lauder Companies Inc is a multinational beauty and cosmetics company.

**2. Return Rate Comparison**
----------------------------

| **Metric** | **EL** | **VOO** |
| --- | --- | --- |
| **Return Rate (rate)** | -25.64% | 93.36% |
| **Return Rate (rate_vs)** | N/A | N/A |

The divergence of the provided data is N/A.

**3. Alpha, Beta Analysis**
-------------------------

| **Year** | **CAGR** | **MDD** | **Alpha** | **Beta** | **Cap** |
| --- | --- | --- | --- | --- | --- |
| **2016-2018** | 22.0% | 19.7% | 18.0% | 0.8 | 46.9B |
| **2017-2019** | 59.0% | 19.7% | 41.0% | 0.9 | 74.4B |
| **2018-2020** | 10.0% | 21.2% | -11.0% | 0.9 | 95.9B |
| **2019-2021** | 46.0% | 21.2% | 3.0% | 1.0 | 133.4B |
| **2020-2022** | -43.0% | 50.3% | -41.0% | 1.1 | 89.4B |
| **2021-2023** | -68.0% | 58.4% | -69.0% | 1.3 | 52.7B |
| **2022-2024** | -101.0% | 64.6% | -121.0% | 1.3 | 27.0B |
| **2023-2025** | -44.0% | 63.7% | -106.0% | 1.3 | 37.7B |

**4. Recent Stock Price Fluctuations**
----------------------------------

| **Metric** | **Value** |
| --- | --- |
| **Close** | $115.05 |
| **Last-Market Change** | -0.52% |
| **5-day SMA** | $115.20 |
| **20-day SMA** | $109.67 |
| **60-day SMA** | $100.60 |

**5. RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**
----------------------------------------------------------------

| **Metric** | **Value** |
| --- | --- |
| **MRI** | 0.80 |
| **RSI** | 64.82 |
| **PPO** | 0.35 |
| **Hybrid Signal** | Buy |
| **Risk Level** | Medium |
| **Recent Relative Divergence Change** | 0 |
| **7-day Rank Change** | 0 |
| **7-day Dynamic Expected Return Change** | 0 |

**6. Recent News & Significant Events**
--------------------------------------

1. **2026-01-17:** Is Estée Lauder (EL) Now Fairly Priced After Strong One Year Share Price Recovery
2. **2026-01-17:** Estee Lauder Companies (NYSE:EL) Raised to "Buy" at Wall Street Zen
3. **2026-01-11:** What Does The Estée Lauder Companies Inc.'s (NYSE:EL) Share Price Indicate?
4. **2026-01-16:** Estee Lauder (EL) Sees Analyst Ratings Boost by JP Morgan
5. **2026-01-14:** New Analyst Forecast: $EL Given $110 Price Target
6. **2026-01-16:** Estee Lauder Companies (NYSE:EL) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

**7. Analyst Opinions**
--------------------

- **Key:** Buy
- **Mean:** 2.42 (~Buy)
- **Opinions:** 24
- **Target Price (avg/high/low):** 108.96 / 131.00 / 65.00

**8. Recent Earnings Analysis**
-----------------------------

| **Date** | **EPS** | **Revenue** |
| --- | --- | --- |
| **2025-10-30** | 0.13 | $3.48B |
| **2025-05-01** | 0.44 | $3.55B |
| **2025-02-04** | -1.64 | $4.00B |
| **2024-10-31** | -0.43 | $3.36B |
| **2025-10-30** | -0.43 | $3.36B |

**9. Financial Information**
-------------------------

### Revenue and Profitability

| **Quarter** | **Revenue** | **Profit Margin** |
| --- | --- | --- |
| **2025-09-30** | $3.48B | 73.37% |
| **2025-06-30** | $3.41B | 72.00% |
| **2025-03-31** | $3.55B | 74.96% |
| **2024-12-31** | $4.00B | 76.10% |
| **2024-09-30** | $3.36B | 72.39% |

### Capital and Profitability

| **Quarter** | **Equity** | **ROE** |
| --- | --- | --- |
| **2025-09-30** | $3.89B | 1.21% |
| **2025-06-30** | $3.87B | -14.13% |
| **2025-03-31** | $4.34B | 3.66% |
| **2024-12-31** | $4.17B | -14.15% |
| **2024-09-30** | $5.08B | -3.07% |

**10. Comprehensive Analysis (Summary of Previous Items)**
----------------------------------------------------

Given the current trends, recent stock price fluctuations, Alpha, Beta analysis, RSI, PPO index indicators, and other relevant data, Estee Lauder Companies Inc (EL) appears to be in a difficult position, especially with the large decline in stock price in the last quarter.

However, the recent news and significant events show that analysts are increasing their buy ratings on EL, which may lead to increased investment and potentially a turnaround in the stock's performance.

Given the current market conditions, investors may want to approach EL with caution and consider diversifying their portfolios.

**Important Information:**

* MRI: 0.80 (Moderate Risk Recommended)
* EPS: -0.43 (Negative Earnings Per Share in the last Quarter)
* Revenue: $3.36B (Decrease in Revenue in the last Quarter)
* ROE: -14.15% (Negative Return on Equity in the last Quarter)

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.